Search this Site
Custom Search
Terbinafine News
Taro Receives Tentative Approval for Terbinafine HCl Cream 1% ANDA; Generic Equivalent to Lamisil(R)
Hawthorne, N.Y. -- Taro Pharmaceutical Industries Ltd. (\"Taro,\" NASDAQ: TARO) reported today that its U.S. affiliate has received tentative approval from the U.S. Food and Drug Administration (\"FDA\") for its Abbreviated New...
Terbinafine (Lamisil) More Effective than Itraconazole (Sporanox) for Onychomycosis in Older Patients: Presented at AAD
San Francisco, CA -- Treatment of onychomycosis, the most common nail disease, in older patients is significantly more effective with terbinafine (Lamisil) 250 mg/day than with intermittent itraconazole (Sporanox).
Continuous Terbinafine Superior to Pulse-Dose Regimen for Onychomycosis
Standard continuous-dose terbinafine is more effective than pulse-dose terbinafine for treating onychomycosis, according to the results of a double-blind, randomized trial, reported in the October issue of the Journal of the...
Displaying results 16 to 18 out of 18